Go to article
Posted by CoV Report on June 9, 2021 12:18 pmTags: Categories: US National Stories
An analysis of blood from people who had received the Johnson & Johnson COVID-19 vaccine found a lower level of neutralizing antibodies against viral variants but a strong response involving T cells.
(Image credit: Lukas Schulze/Getty Images)
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply